These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20484933)

  • 1. Treatment of primary systemic vasculitis with the inosine monophosphate dehydrogenase inhibitor mycophenolic acid.
    Hiemstra TF; Jones RB; Jayne DR
    Nephron Clin Pract; 2010; 116(1):c1-10. PubMed ID: 20484933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of inosin-5'-monophosphate dehydrogenase activity during maintenance therapy with tacrolimus.
    Maiguma T; Yosida T; Otsubo K; Okabe Y; Sugitani A; Tanaka M; Oishi R; Teshima D
    J Clin Pharm Ther; 2010 Feb; 35(1):79-85. PubMed ID: 20175815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower 12-hour trough concentrations of mycophenolic acid in patients with active systemic vasculitides taking mycophenolate mofetil.
    Djabarouti S; Lazaro E; Breilh D; Pellegrin JL; Viallard JF
    J Rheumatol; 2012 Nov; 39(11):2222-3. PubMed ID: 23118295
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
    Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM
    Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil: a report of the consensus panel.
    Shaw LM; Sollinger HW; Halloran P; Morris RE; Yatscoff RW; Ransom J; Tsina I; Keown P; Holt DW; Lieberman R
    Ther Drug Monit; 1995 Dec; 17(6):690-9. PubMed ID: 8588243
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolic acid, mycophenolate mofetil, mizoribine, ribavirin, and 7-nitroindole inhibit propagation of Babesia parasites by targeting inosine 5'-monophosphate dehydrogenase.
    Cao S; Aboge GO; Terkawi MA; Zhou M; Kamyingkird K; Moumouni PF; Masatani T; Igarashi I; Nishikawa Y; Suzuki H; Xuan X
    J Parasitol; 2014 Aug; 100(4):522-6. PubMed ID: 24580148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of mycophenolate mofetil: recent data and clinical consequences].
    Thervet E; Anglicheau D; Legendre C
    Nephrologie; 2001; 22(7):331-7. PubMed ID: 11817210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil: a dermatologic perspective.
    Mydlarski PR
    Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.
    Katz KH; Marks JG; Helm KF
    J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients.
    Thi MT; Mourad M; Capron A; Tshinanu FM; Vincent MF; Wallemacq P
    Clin Biochem; 2015 Apr; 48(6):401-5. PubMed ID: 25523299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity.
    Su H; Gunter JH; de Vries M; Connor T; Wanyonyi S; Newell FS; Segal D; Molero JC; Reizes O; Prins JB; Hutley LJ; Walder K; Whitehead JP
    Biochem Biophys Res Commun; 2009 Aug; 386(2):351-5. PubMed ID: 19523919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil.
    Sanquer S; Breil M; Baron C; Dhamane D; Astier A; Lang P
    Clin Pharmacol Ther; 1999 Jun; 65(6):640-8. PubMed ID: 10391669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of inosine monophosphate dehydrogenase activity by the plasma of heart transplant recipients receiving mycophenolate mofetil.
    Griesmacher A; Weigel G; Seebacher G; Mallinger R; Laufer G; Müller MM
    Adv Exp Med Biol; 1998; 431():537-41. PubMed ID: 9598124
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate-mofetil in the treatment of refractory multiple sclerosis.
    Ahrens N; Salama A; Haas J
    J Neurol; 2001 Aug; 248(8):713-4. PubMed ID: 11569905
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M
    Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New trends in chemotherapy of systemic lupus erythematosus: treatment with mycophenolate mofetil].
    Shekshina SV; Kliukvina NG; Nasonov EL; Nasonova VA
    Klin Med (Mosk); 2002; 80(4):26-30. PubMed ID: 12043258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.
    Vethe NT; Mandla R; Line PD; Midtvedt K; Hartmann A; Bergan S
    Scand J Clin Lab Invest; 2006; 66(1):31-44. PubMed ID: 16464785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil.
    Allison AC; Eugui EM
    Immunol Rev; 1993 Dec; 136():5-28. PubMed ID: 7907572
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients.
    Takebe N; Cheng X; Wu S; Bauer K; Goloubeva OG; Fenton RG; Heyman M; Rapoport AP; Badros A; Shaughnessy J; Ross D; Meisenberg B; Tricot G
    Clin Cancer Res; 2004 Dec; 10(24):8301-8. PubMed ID: 15623606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.